Prostate cancer decisions — 2017

The Veteran's appeal is dismissed regarding his claim for prostate cancer to include as secondary to herbicide exposure. The request for revision of the March 2006 decision based on CUE in the effective date of the 70 percent rating for PTSD with depression is denied.

The reduction from a 100% to a 20% rating for prostate cancer was upheld as the condition had improved and remained in remission.

The Veteran's claim for an initial compensable rating for residuals of prostate cancer prior to June 24, 2016 is being remanded due to the need to obtain additional private treatment records.

The Veteran's prostate cancer is not service connected, but his erectile dysfunction (for the purpose of special monthly compensation) is denied.

The Veteran's prostate cancer in remission, erectile dysfunction, and pelvic surgical scar are all being reviewed for potential increased ratings. The VA will obtain updated treatment records and schedule the Veteran for a VA examination to assess his current conditions.

The Board has remanded the case due to inadequate medical opinions and missing VA treatment records. The Veteran's claim for service connection for post-operative residuals of prostate cancer will be further evaluated after obtaining additional evidence.

The Veteran's cause of death is being remanded due to the need for additional information regarding his service and exposure to herbicides. The appellant seeks service connection for the cause of death based on presumed Agent Orange exposure.

The Veteran's prostate cancer was not present during service or for many years thereafter. The Veteran served at Camp Leune, but there is no evidence of actual exposure to contaminated water that could support a claim based on herbicide exposure. Therefore, the claim for service connection for prostate cancer is denied.

The Veteran's service-connected residuals of prostate cancer are rated at 40% prior to November 8, 2014 and at 60% thereafter. The Veteran's service-connected hepatitis B is currently not symptomatic and thus does not meet the criteria for a compensable rating.

The Veteran's prostate cancer and its resulting complications, including erectile dysfunction, were not the result of VA treatment, including testosterone replacement therapy.,The Veteran's erectile dysfunction is not caused or aggravated by a service-connected disability.

The Veteran seeks service connection for prostate cancer, which he contends is related to ionizing radiation exposure during his military service. The case has been remanded due to the need for a dose assessment of exposure and an advisory opinion on whether the Veteran's radiogenic disease (prostate cancer) is related to his in-service radiation exposure.

The Veteran's increased disability rating claim for prostate cancer residuals from August 1, 2010 was denied as the reduction in evaluation to 60% was proper by operation of law under DC 7528. The Board found that there was no evidence of active malignancy or recurrence after August 1, 2010.

The Board has determined that the reduction of the evaluation for prostate cancer from 100 percent to 60 percent, effective September 1, 2009, was proper as the Veteran's prostate cancer is in remission.

The Veteran's claim for service connection for a respiratory/pulmonary disorder, including tuberculosis and asbestosis, was denied due to lack of evidence. New evidence did not raise a reasonable possibility of substantiating the claim.,The Veteran's claim for service connection for prostate cancer was previously denied based on lack of exposure to Agent Orange. New evidence suggests possible exposure during service in Vietnam.